Cargando…
Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
BACKGROUND: Conflicting results about the association between expression level of excision repair cross-complementation group 1 (ERCC1) and clinical outcome in patients with colorectal cancer (CRC) receiving chemotherapy have been reported. Thus, we searched the available articles and performed the...
Autores principales: | Li, Mu-Xing, Bi, Xin-Yu, Zhao, Hong, Huang, Zhen, Han, Yue, Zhao, Dong-Bin, Zhao, Jian-Jun, Cai, Jian-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804441/ https://www.ncbi.nlm.nih.gov/pubmed/26904994 http://dx.doi.org/10.4103/0366-6999.176993 |
Ejemplares similares
-
Extralevator abdominoperineal excision versus abdominoperineal excision for low rectal cancer: a meta-analysis
por: Qi, Xin-Yu, et al.
Publicado: (2019) -
High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis
por: Huang, Qi, et al.
Publicado: (2017) -
Deoxyribonucleic acid repair gene X-ray repair cross-complementing group 1 polymorphisms and non-carcinogenic disease risk in different populations: A meta-analysis
por: Larijani, Bagher, et al.
Publicado: (2013) -
Prognostic value of YKL-40 in colorectal carcinoma patients: A meta-analysis
por: Wang, Jian, et al.
Publicado: (2022) -
Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
por: Wu, Dong-Mei, et al.
Publicado: (2017)